Amneal Begins Supplying Over-the-Counter Naloxone Hydrochlor

Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that it has begun supplying its over-the-counter Naloxone Hydrochloride (Naloxone HCI) Nasal Spray, USP, 4mg to U.S. retail pharmacies and the State of California. The product...

Related Keywords

United States , New Jersey , State Of California , California , Ireland , America , Maryll Toufanian , Randy Boyer , Exchange Commission , Product Service , Nasdaq , Drug Administration , Amneal Pharmaceuticals Inc , Government Affairs , Emergent Operations Ireland , Naloxone Access Initiative , Amneal Group , Naloxone Hydrochloride , Nasal Spray , Naloxone Access , Executive Vice President , Chief Commercial Officer , Regulatory Strategy , Securities Litigation Reform Act , Annual Report ,